SGI
MLAB icon

Summit Global Investments’s Mesa Laboratories MLAB Stock Holding History

Summit Global Investments’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,000
Closed -$845K – 477
2022
Q3 		$845K Buy
6,000
+1,500
+33% +$274K 0.08% 217
2022
Q2 		$918K Buy
4,500
+2,800
+165% +$613K 0.08% 233
2022
Q1 		$433K Hold
1,700
– – 0.03% 353
2021
Q4 		$558K Sell
1,700
-1,800
-51% -$565K 0.04% 331
2021
Q3 		$1.06M Buy
+3,500
New +$995K 0.08% 192

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Summit Global Investments's MLAB Position: Q4 2022 in Review

Summit Global Investments sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 6,000 shares — an estimated $845K sold.

Summit Global Investments first reported a position in MLAB in Q3 2021 and held it in 5 quarters. The position peaked at $1.06M in Q3 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

  • Summit Global Investments reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
  • Summit Global Investments sold 6,000 Mesa Laboratories shares in Q4 2022, an estimated $845K.
  • Summit Global Investments first reported a position in Mesa Laboratories in Q3 2021 and held it in 5 quarters.
  • Summit Global Investments's Mesa Laboratories position peaked at $1.06M in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on Summit Global Investments's 13F filing for Q4 2022, filed 31 Jan 2023.